4D Pharma PLC (LBPS) Stock Analyst Ratings

USA • Nasdaq • NASDAQ:LBPS • US35085K1097

1.65
+0.04 (+2.48%)
Last: Jun 24, 2022, 08:00 PM
Buy % Consensus

80

ChartMill assigns a Buy % Consensus number of 80% to LBPS. The Buy consensus is the weighted average rating of the current analysts ratings.

  • Analysts have set a mean price target forecast of 7.52. This target is 356.04% above the current price.
  • LBPS was analyzed by 6 analysts. The buy percentage consensus is at 80. So analysts seem to be have mildly positive about LBPS.
  • In the previous month the buy percentage consensus was at a similar level.
  • LBPS was analyzed by 6 analysts. More opinions would make the average more meaningful.

Related screens

LBPS Historical Analyst RatingsLBPS Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -42 -38 -34 -30 -26 -22 -18 -14 -10 -6 -2 1 2 3 4 5

Price Target & Forecast

Price Low Median Mean High 1.657.457.527.527.75 - 351.56% 356.04% 356.04% 369.45%

Related screens

LBPS Current Analyst RatingLBPS Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 0 0 0 0 0
Up and Down Grades
Date Firm Action Rating
2022-06-27 Chardan Capital Downgrade Buy -> Neutral

4D Pharma PLC / LBPS FAQ

What is the average price target for 4D Pharma PLC (LBPS) stock?

6 analysts have analysed LBPS and the average price target is 7.52 null. This implies a price increase of 356.04% is expected in the next year compared to the current price of 1.65.


How do analysts rate 4D Pharma PLC (LBPS)?

The consensus rating for 4D Pharma PLC (LBPS) is 80 / 100 . This indicates that analysts generally have a positive outlook on the stock.


What is the number of analysts for LBPS stock?

The number of analysts covering 4D Pharma PLC (LBPS) is 6.